Pancreatic Cancer Research

ResearcherHenry Ford Health + Michigan State University Health SciencesActive in the last 2 years

Maria Diab

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-4809-9535; OpenAlex author ID A5085875893. Sources: OpenAlex.

Their work

Papers
7 (first author 1, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
23
Papers, trials and grants by year

2016: 1 paper · 2017: none · 2018: none · 2019: 1 paper · 2020: 1 paper · 2021: 1 paper · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 2 papers

Papers 7

  1. A phase Ib/II trial of XL888 (HSP90 inhibitor) and pembrolizumab in metastatic pancreatic cancer with translational immune profiling. First author DOI 10.1016/j.canlet.2025.218233↗
  2. High-Dimensional Protein Analysis Uncovers Distinct Immunologic and Stromal Features in Primary and Metastatic Pancreatic Ductal Adenocarcinoma. Co-author DOI 10.1158/0008-5472.can-25-1697↗
  3. New Therapeutic Targets in RAS Wild-type Pancreatic Cancer. Co-author DOI 10.1007/s11864-024-01242-z↗
  4. Pancreatic adenocarcinoma: molecular drivers and the role of targeted therapy. Last author DOI 10.1007/s10555-020-09948-w↗
  5. Calcium Release-Activated Calcium (CRAC) Channel Inhibition Suppresses Pancreatic Ductal Adenocarcinoma Cell Proliferation and Patient-Derived Tumor Growth. Co-author DOI 10.3390/cancers12030750↗
  6. Pharmacotherapeutic strategies for treating pancreatic cancer: advances and challenges. Co-author DOI 10.1080/14656566.2018.1561869↗
  7. The Role of microRNAs in the Diagnosis and Treatment of Pancreatic Adenocarcinoma. Co-author DOI 10.3390/jcm5060059↗

Closest collaborators

The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chrystal M Paulos · 2 shared papers, 2026 · strength 0.47
  2. Emily R. Greene · 2 shared papers, 2026 · strength 0.47
  3. Cameron J. Herting · 2 shared papers, 2026 · strength 0.47
  4. Natalie K. Horvat · 2 shared papers, 2026 · strength 0.47
  5. Olatunji Boladale Alese · 2 shared papers, 2026 · strength 0.47
  6. Gregory B. Lesinski · 2 shared papers, 2026 · strength 0.47
  7. Bassel F. El‐Rayes · 2 shared papers, 2026 · strength 0.47
  8. Asfar Sohail Azmi · 3 shared papers, 2016–2020 · strength 0.31
  9. Philip A. Philip · 3 shared papers, 2016–2020 · strength 0.31
  10. Olumide B. Gbolahan · 1 shared paper, 2026 · strength 0.24
  11. Juan Manuel Sarmiento · 1 shared paper, 2026 · strength 0.23
  12. Alyssa M. Krasinskas · 1 shared paper, 2026 · strength 0.23
  13. Mihir Maheshkumar Shah · 1 shared paper, 2026 · strength 0.23
  14. Shishir Kumar Maithel · 1 shared paper, 2026 · strength 0.23
  15. Bayan A. Al-Share · 1 shared paper, 2021 · strength 0.22
  16. Ramzi M. Mohammad · 2 shared papers, 2016–2020 · strength 0.17
  17. Steve H. Kim · 1 shared paper, 2020 · strength 0.09
  18. Rachel E. Sexton · 1 shared paper, 2020 · strength 0.09
  19. Anteneh A. Tesfaye · 1 shared paper, 2020 · strength 0.09
  20. Husain Yar Khan · 1 shared paper, 2020 · strength 0.09
  21. Amro Aboukameel · 1 shared paper, 2020 · strength 0.09
  22. Mandana Kamgar · 1 shared paper, 2020 · strength 0.09
  23. Irfana Muqbil · 1 shared paper, 2016 · strength 0.08

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.